Camarda Financial Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,217
Closed -$205K 68
2022
Q2
$205K Buy
+5,217
New +$205K 0.2% 68